Vertex Pharmaceuticals (VRTX) Intangibles (2009 - 2026)

Vertex Pharmaceuticals' (VRTX) quarterly Intangibles came in at $418.5 million in Q1 2026, down 5.15% year-on-year from $441.2 million in Q1 2025, and down 1.34% quarter-over-quarter from $424.2 million in Q4 2025.

Vertex Pharmaceuticals (VRTX) Intangibles (2009 - 2026) Analysis & Trends

Vertex Pharmaceuticals' Intangibles history runs 18 years deep, the most recent figure standing at $418.5 million for Q1 2026.

  • On a quarterly basis, Intangibles fell 5.15% year-over-year to $418.5 million in Q1 2026; TTM through Mar 2026 was $418.5 million, a 5.15% decrease from a year earlier, with the FY2025 full-year figure at $424.2 million, down 48.64% from the prior year.
  • Intangibles declined to $418.5 million in Q1 2026 per VRTX's latest filing, from $424.2 million in the prior quarter.
  • Across five years, Intangibles topped out at $839.9 million in Q4 2023 and bottomed at $387.0 million in Q2 2022.
  • The 5-year median for Intangibles is $603.6 million (2022), against an average of $595.5 million.
  • Across the five-year window, Intangibles soared 55.97% in 2023 and slumped 48.64% in 2025, its largest moves.
  • Year by year, Intangibles stood at $603.6 million in 2022, then jumped by 39.15% to $839.9 million in 2023, then retreated by 1.67% to $825.9 million in 2024, then slumped by 48.64% to $424.2 million in 2025, then retreated by 1.34% to $418.5 million in 2026.
  • Per Business Quant, the three latest VRTX Intangibles figures stand at $418.5 million (Q1 2026), $424.2 million (Q4 2025), and $429.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 16.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 11,640.44
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 61.68 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.92 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 418.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.29 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 266.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 55.80 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 418.50 Mn
Dec 31, 2025 424.20 Mn
Sep 30, 2025 429.80 Mn
Jun 30, 2025 435.50 Mn
Mar 31, 2025 441.20 Mn
Dec 31, 2024 825.90 Mn
Sep 30, 2024 831.60 Mn
Jun 30, 2024 837.50 Mn
Mar 31, 2024 834.90 Mn
Dec 31, 2023 839.90 Mn
Sep 30, 2023 603.60 Mn
Jun 30, 2023 603.60 Mn
Mar 31, 2023 603.60 Mn
Dec 31, 2022 603.60 Mn
Sep 30, 2022 603.60 Mn
Jun 30, 2022 387.00 Mn
Mar 31, 2022 400.00 Mn
Dec 31, 2021 400.00 Mn
Sep 30, 2021 400.00 Mn
Jun 30, 2021 400.00 Mn